Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

SNSSD

Sunesis Pharmaceuticals, Inc. (MM) (SNSSD)

Sunesis Pharmaceuticals, Inc. (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SNSSD

1

Data	Hora	Fonte	Título	Código	Companhia
10/03/2011	09:30	GlobeNewswire Inc.	Sunesis Issued Important European Patent Covering Vosaroxin Clinical Formulation	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
09/03/2011	09:29	GlobeNewswire Inc.	Sunesis to Present at ROTH 23rd Annual OC Growth Stock Conference	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
03/03/2011	09:30	GlobeNewswire Inc.	Sunesis Pharmaceuticals Regains NASDAQ Compliance	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
02/03/2011	22:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
01/03/2011	09:30	GlobeNewswire Inc.	Sunesis to Present at Cowen and Company 31st Annual Health Care Conference	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
24/02/2011	10:46	Marketwired	Regulatory Process an Ongoing Challenge for Speculative Biotech Firms	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
24/02/2011	09:30	GlobeNewswire Inc.	Sunesis to Join Panel Discussion at the RBC Capital Markets' Healthcare Conference	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
23/02/2011	09:30	GlobeNewswire Inc.	Sunesis Receives FDA Fast Track Designation for Vosaroxin in AML	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)
18/02/2011	19:17	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:SNSSD	Sunesis Pharmaceuticals, Inc. (MM)